Carlsmed (CARL) Asset Utilization Ratio (2025 - 2026)

Carlsmed's (CARL) quarterly Asset Utilization Ratio came in at 0.53 in Q2 2026, up 17.79% quarter-over-quarter from 0.45 in Q1 2026.

Analysis

Carlsmed (CARL) Asset Utilization Ratio (2025 - 2026) Analysis & Trends

Carlsmed (CARL) has reported Asset Utilization Ratio for 2 consecutive years, with 0.53 the latest figure, recorded in Q2 2026.

For the quarter ending Q2 2026, Asset Utilization Ratio changed N/A year-over-year to 0.53; the trailing twelve-month figure through Jun 2026 stood at 0.53 (changed N/A YoY), and the FY2025 full-year result was 0.56, changed N/A from the prior year.
Asset Utilization Ratio grew to 0.53 in Q2 2026 per CARL's latest filing, from 0.45 in the prior quarter.
Across five years, Asset Utilization Ratio topped out at 0.53 in Q2 2026 and bottomed at 0.38 in Q4 2025.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Abbott Laboratories	187.42 Bn	182.47 Bn	7.27 Bn	0.42
2	Intuitive Surgical	129.78 Bn	124.69 Bn	1.96 Bn	0.54
3	Medtronic	120.53 Bn	112.33 Bn	6.34 Bn	0.40
4	Stryker	116.28 Bn	112.80 Bn	4.50 Bn	0.55
5	Boston Scientific	69.29 Bn	68.99 Bn	3.85 Bn	0.47
6	Edwards Lifesciences	51.83 Bn	47.68 Bn	1.35 Bn	0.48
7	Alcon	34.36 Bn	32.91 Bn	1.68 Bn	0.34
8	Dexcom	33.17 Bn	31.23 Bn	830.00 Mn	0.76
9	Resmed	32.94 Bn	31.47 Bn	861.22 Mn	0.64
10	Carlsmed	424.72 Mn	311.42 Mn	14.54 Mn	0.53

Historic Data

Download Data